In vitro and in vivo toxicity studies of copper sulfide nanoplates for potential photothermal applications

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 4, 2015, Pages 901-912

  Feng, Wei ^a   Nie, Wei ^a   Cheng, Yanhua ^a   Zhou, Xiaojun ^a   Chen, Liang ^a   Qiu, Kexin ^a   Chen, Zhigang ^a   Zhu, Meifang ^a   He, Chuanglong ^a  

^a DONGHUA UNIVERSITY   (China)

Author keywords

Biocompatibility; Biodistribution; Copper sulfide nanoplates; Photothermal therapy; Toxicity

Indexed keywords

BIOCOMPATIBILITY; DISEASES; DRUG DOSAGE; INDUSTRIAL POISONS; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES; SULFUR COMPOUNDS; TOXICITY;

BIODISTRIBUTIONS; MAXIMUM TOLERATED DOSE; NANOPLATES; PHOTOTHERMAL ABLATION THERAPY; PHOTOTHERMAL APPLICATIONS; PHOTOTHERMAL THERAPY; TOXICITY ASSESSMENT; TREATMENT MODALITY;

COPPER COMPOUNDS;

ALANINE AMINOTRANSFERASE; ALBUMIN; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COPPER DERIVATIVE; COPPER SULFIDE NANOPLATE; CREATININE; F ACTIN; GLOBULIN; NANOMATERIAL; SULFIDE; UNCLASSIFIED DRUG; COPPER; NANOPARTICLE;

ACTIN FILAMENT; ACUTE TOXICITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIOCOMPATIBILITY; BODY WEIGHT; CELL MIGRATION; CELL VIABILITY; CHRONIC TOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOPLASM; CYTOSKELETON; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FECES LEVEL; DRUG STRUCTURE; DRUG TOXICITY; DRUG URINE LEVEL; FEMALE; GLOBULIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; INHIBITORY CONCENTRATION; INTERNALIZATION; KIDNEY; LD50; LIVER; LUNG; LUNG FIBROSIS; MAXIMUM TOLERATED DOSE; MOUSE; NONHUMAN; SPLEEN; SURVIVAL RATE; TOXICITY TESTING; UMBILICAL VEIN ENDOTHELIAL CELL; UREA NITROGEN BLOOD LEVEL; X RAY DIFFRACTION; ZETA POTENTIAL; ANIMAL; CELL LINE; CHEMISTRY; MATERIALS TESTING; NEOPLASMS; PHOTOTHERAPY; PROCEDURES;

ANIMALS; CELL LINE; COPPER; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MATERIALS TESTING; MICE; NANOPARTICLES; NEOPLASMS; PHOTOTHERAPY; SULFIDES;

EID: 84929327079     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.12.015     Document Type: Article

References (49)

1. Peer D., Karp J.M., Hong S., FaroKHzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
2. Jemal A., Center M.M., DeSantis C., Ward E.M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidem Biomar 2010, 19:1893-1907.
3. Chen C.Y., Kim T.H., Wu W.C., Huang C.M., Wei H., Mount C.W., et al. pH-dependent, thermosensitive polymeric nanocarriers for drug delivery to solid tumors. Biomaterials 2013, 34:4501-4509.
4. Mukerjee A., Ranjan A.P., Vishwanatha J.K. Combinatorial nanoparticles for cancer diagnosis and therapy. Curr Med Chem 2012, 19:3714-3721.
5. Xiao Q.F., Zheng X.P., Bu W.B., Ge W.Q., Zhang S.J., Chen F., et al. A core/satellite multifunctional nanotheranostic for in vivo imaging and tumor eradication by radiation/photothermal synergistic therapy. J Am Chem Soc 2013, 135:13041-13048.
6. Geng J.L., Li K., Pu K.Y., Ding D., Liu B. Conjugated polymer and gold nanoparticle co-loaded PLGA nanocomposites with eccentric internal nanostructure for dual-modal targeted cellular imaging. Small 2012, 8:2421-2429.
7. Dong K., Liu Z., Li Z.H., Ren J.S., Qu X.G. Hydrophobic anticancer drug delivery by a 980nm laser-driven photothermal vehicle for efficient synergistic therapy of cancer cells in vivo. Adv Mater 2013, 25:4452-4458.
8. Alkilany A.M., Thompson L.B., Boulos S.P., Sisco P.N., Murphy C.J. Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv Drug Deliv Rev 2012, 64:190-199.
9. Yang K., Hu L.L., Ma X.X., Ye S.Q., Cheng L., Shi X.Z., et al. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv Mater 2012, 24:1868-1872.
10. Chen W.R., Adams R.L., Higgins A.K., Bartels K.E., Nordquist R.E. Photothermal effects on murine mammary tumors using indocyanine green and an 808-nm diode laser: an in vivo efficacy study. Cancer Lett 1996, 98:169-173.
11. Zha Z.B., Yue X.L., Ren Q.S., Dai Z.F. Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells. Adv Mater 2013, 25:777-782.
12. Moon H.K., Lee S.H., Choi H.C. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 2009, 3:3707-3713.
13. Chen Y.W., Chen P.J., Hu S.H., Chen I.W., Chen S.Y. NIR-triggered synergic photo-chemothermal therapy delivered by reduced graphene oxide/carbon/mesoporous silica nanocookies. Adv Funct Mater 2014, 24:451-459.
14. Lambert T.N., Andrews N.L., Gerung H., Boyle T.J., Oliver J.M., Wilson B.S., et al. Water-soluble germanium(0) nanocrystals: cell recognition and near-infrared photothermal conversion properties. Small 2007, 3:691-699.
15. Huang X.Q., Tang S.H., Mu X.L., Dai Y., Chen G.X., Zhou Z.Y., et al. Freestanding palladium nanosheets with plasmonic and catalytic properties. Nat Nanotechnol 2011, 6:28-32.
16. 2 nano-sheets for combined photothermal and chemotherapy of cancer. Adv Mater 2014, 26:3433-3440.
17. 2 nanosheets as a multifunctional theranostic agent for in vivo dual-modal CT/photoacoustic imaging guided photothermal therapy. Adv Mater 2014, 26:1886-1893.
18. Huang X.H., El-Sayed I.H., Qian W., El-Sayed M.A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006, 128:2115-2120.
19. Yuan H., Fales A.M., Vo-Dinh T. TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. J Am Chem Soc 2012, 134:11358-11361.
20. Yavuz M.S., Cheng Y.Y., Chen J.Y., Cobley C.M., Zhang Q., Rycenga M., et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater 2009, 8:935-939.
21. Liu H.Y., Chen D., Li L.L., Liu T.L., Tan L.F., Wu X.L., et al. Multifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity. Angew Chem Int Ed 2011, 50:891-895.
22. Xiao Z.Y. CuS nanoparticles: clinically favorable materials for photothermal applications?. Nanomedicine 2014, 9:373-375.
23. Li Y.B., Lu W., Huang Q.A., Huang M.A., Li C., Chen W. Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine 2010, 5:1161-1171.
24. Hessel C.M., Pattani V.P., Rasch M., Panthani M.G., Koo B., Tunnell J.W., et al. Copper selenide nanocrystals for photothermal therapy. Nano Lett 2011, 11:2560-2566.
25. Li W.H., Zamani R., Gil P.R., Pelaz B., Ibanez M., Cadavid D., et al. CuTe nanocrystals: shape and size control, plasmonic properties, and use as SERS probes and photothermal agents. J Am Chem Soc 2013, 135:7098-7101.
26. 5 nanocrystals: a photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo. ACS Nano 2011, 5:9761-9771.
27. Guo L.R., Panderi I., Yan D.D., Szulak K., Li Y.J., Chen Y.T., et al. A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity. ACS Nano 2013, 7:8780-8793.
28. Tian Q.W., Tang M.H., Sun Y.G., Zou R.J., Chen Z.G., Zhu M.F., et al. Hydrophilic flower-like CuS superstructures as an efficient 980nm laser-driven photothermal agent for ablation of cancer cells. Adv Mater 2011, 23:3542-3547.
29. Goel S., Chen F., Cai W.B. Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics. Small 2014, 10:631-645.
30. Feng W., Zhou X.J., He C.L., Qiu K.X., Nie W., Chen L., et al. Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug delivery: layer thickness-dependent release profiles and biocompatibility. J Mater Chem B 2013, 1:5886-5898.
31. Yu T., Greish K., McGill L.D., Ray A., Ghandehari H. Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold. ACS Nano 2012, 6:2289-2301.
32. Zhang J., Zhang Z. Hydrothermal synthesis and optical properties of CuS nanoplates. Mater Lett 2008, 62:2279-2281.
33. Lesniak A., Fenaroli F., Monopoli M.R., Aberg C., Dawson K.A., Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 2012, 6:5845-5857.
34. Safi M., Courtois J., Seigneuret M., Conjeaud H., Berret J.F. The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 2011, 32:9353-9363.
35. Bulcke F., Thiel K., Dringen R. Uptake and toxicity of copper oxide nanoparticles in cultured primary brain astrocytes. Nanotoxicology 2013, 1-11.
36. Chang J.S., Chang K.L.B., Hwang D.F., Kong Z.L. In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ Sci Technol 2007, 41:2064-2068.
37. Zhang T.T., Stilwell J.L., Gerion D., Ding L.H., Elboudwarej O., Cooke P.A., et al. Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. Nano Lett 2006, 6:800-808.
38. Schottenfeld D., Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 2006, 56:69-83.
39. Soenen S.J., Rivera-Gil P., Montenegro J.M., Parak W.J., De Smedt S.C., Braeckmans K. Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation. Nano Today 2011, 6:446-465.
40. Gourlay C.W., Ayscough K.R. The actin cytoskeleton: a key regulator of apoptosis and ageing?. Nat Rev Mol Cell Biol 2005, 6:583-589.
41. Rangel M., Prado M.P., Konno K., Naoki H., Freitas J.C., Machado-Santelli G.M. Cytoskeleton alterations induced by geodia corticostylifera depsipeptides in breast cancer cells. Peptides 2006, 27:2047-2057.
42. Ndozangue-Touriguine O., Hamelin J., Breard J. Cytoskeleton and apoptosis. Biochem Pharmacol 2008, 76:11-18.
43. Arredondo M., Nunez M. Iron and copper metabolism. Mol Aspects Med 2005, 26:313-327.
44. Wang J., Long L., Xie D., Zhan Y. Highly selective fluorescence turn-on sensor for hydrogen sulfide and imaging in living cells. J Lumin 2013, 139:40-46.
45. 4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv Mater 2007, 19:3163-3166.
46. Yu T., Malugin A., Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 2011, 5:5717-5728.
47. Liu X.S., Jin Q., Ji Y., Ji J. Minimizing nonspecific phagocytic uptake of biocompatible gold nanoparticles with mixed charged zwitterionic surface modification. J Mater Chem 2012, 22:1916-1927.
48. Dobrovolskaia M.A., Aggarwal P., Hall J.B., McNeil S.E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 2008, 5:487-495.
49. Huang X.L., Li L.L., Liu T.L., Hao N.J., Liu H.Y., Chen D., et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 2011, 5:5390-5399.